Checkpoint Capital L.P. / PLRX
Checkpoint Capital L.P.’s Pliant Therapeutics Inc Position
Does Checkpoint Capital L.P. own Pliant Therapeutics Inc (PLRX)? Not currently — the last reported position was 535.5K shares worth $7M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$7M
Q4 2024
Shares
535.5K
% of Portfolio
+3.59%
Quarters Held
3
position exited
Position History PLRX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Checkpoint Capital L.P.’s full portfolio or all institutional holders of PLRX.